198 related articles for article (PubMed ID: 22239437)
1. Targeting the Fas/FasL signaling pathway in cancer therapy.
Villa-Morales M; Fernández-Piqueras J
Expert Opin Ther Targets; 2012 Jan; 16(1):85-101. PubMed ID: 22239437
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity.
Mitsiades N; Yu WH; Poulaki V; Tsokos M; Stamenkovic I
Cancer Res; 2001 Jan; 61(2):577-81. PubMed ID: 11212252
[TBL] [Abstract][Full Text] [Related]
3. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M
J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692
[TBL] [Abstract][Full Text] [Related]
4. Overexpressed exogenous IL-4 And IL-10 paradoxically regulate allogenic T-cell and cardiac myocytes apoptosis through FAS/FASL pathway.
Furukawa H; Oshima K; Tung T; Cui G; Laks H; Sen L
Transplantation; 2008 Feb; 85(3):437-46. PubMed ID: 18301335
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells.
Villunger A; Egle A; Kos M; Hartmann BL; Geley S; Kofler R; Greil R
Cancer Res; 1997 Aug; 57(16):3331-4. PubMed ID: 9269989
[TBL] [Abstract][Full Text] [Related]
6. Critical roles for JNK, c-Jun, and Fas/FasL-Signaling in vitamin E analog-induced apoptosis in human prostate cancer cells.
Jia L; Yu W; Wang P; Li J; Sanders BG; Kline K
Prostate; 2008 Mar; 68(4):427-41. PubMed ID: 18196534
[TBL] [Abstract][Full Text] [Related]
7. The Fas signalling pathway and its role in the pathogenesis of cancer.
Houston A; O'Connell J
Curr Opin Pharmacol; 2004 Aug; 4(4):321-6. PubMed ID: 15251123
[TBL] [Abstract][Full Text] [Related]
8. SERPINA3K induces apoptosis in human colorectal cancer cells via activating the Fas/FasL/caspase-8 signaling pathway.
Yao Y; Li L; Huang X; Gu X; Xu Z; Zhang Y; Huang L; Li S; Dai Z; Li C; Zhou T; Cai W; Yang Z; Gao G; Yang X
FEBS J; 2013 Jul; 280(14):3244-55. PubMed ID: 23615374
[TBL] [Abstract][Full Text] [Related]
9. Fas/CD95 death receptor and lipid rafts: new targets for apoptosis-directed cancer therapy.
Mollinedo F; Gajate C
Drug Resist Updat; 2006; 9(1-2):51-73. PubMed ID: 16687251
[TBL] [Abstract][Full Text] [Related]
10. Fas receptor-mediated apoptosis: a clinical application?
Timmer T; de Vries EG; de Jong S
J Pathol; 2002 Feb; 196(2):125-34. PubMed ID: 11793363
[TBL] [Abstract][Full Text] [Related]
11. PEG-liposomal oxaliplatin induces apoptosis in human colorectal cancer cells via Fas/FasL and caspase-8.
Yang C; Liu HZ; Fu ZX
Cell Biol Int; 2012 Mar; 36(3):289-96. PubMed ID: 21888623
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin and selenium cooperatively induce fas signaling in the absence of Fas/Fas ligand interaction.
Li S; Zhou Y; Dong Y; Ip C
Anticancer Res; 2007; 27(5A):3075-82. PubMed ID: 17970047
[TBL] [Abstract][Full Text] [Related]
13. Fas and Fas ligand interactions in malignant disease.
Owen-Schaub L; Chan H; Cusack JC; Roth J; Hill LL
Int J Oncol; 2000 Jul; 17(1):5-12. PubMed ID: 10853011
[TBL] [Abstract][Full Text] [Related]
14. A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancer.
Hall SJ; Canfield SE; Yan Y; Hassen W; Selleck WA; Chen SH
Gene Ther; 2002 Apr; 9(8):511-7. PubMed ID: 11948376
[TBL] [Abstract][Full Text] [Related]
15. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
Que FG; Phan VA; Phan VH; Celli A; Batts K; LaRusso NF; Gores GJ
Hepatology; 1999 Dec; 30(6):1398-404. PubMed ID: 10573518
[TBL] [Abstract][Full Text] [Related]
16. The role of Fas/FasL in the metastatic potential of osteosarcoma and targeting this pathway for the treatment of osteosarcoma lung metastases.
Gordon N; Kleinerman ES
Cancer Treat Res; 2009; 152():497-508. PubMed ID: 20213411
[TBL] [Abstract][Full Text] [Related]
17. Seawater induces apoptosis in alveolar epithelial cells via the Fas/FasL-mediated pathway.
Han F; Luo Y; Li Y; Liu Z; Xu D; Jin F; Li Z
Respir Physiol Neurobiol; 2012 Jul; 182(2-3):71-80. PubMed ID: 22609371
[TBL] [Abstract][Full Text] [Related]
18. The role of Fas and FasL as mediators of anticancer chemotherapy.
Poulaki V; Mitsiades CS; Mitsiades N
Drug Resist Updat; 2001 Aug; 4(4):233-42. PubMed ID: 11991678
[TBL] [Abstract][Full Text] [Related]
19. ROS-mediated p38alpha MAPK activation and ERK inactivation responsible for upregulation of Fas and FasL and autocrine Fas-mediated cell death in Taiwan cobra phospholipase A(2)-treated U937 cells.
Liu WH; Cheng YC; Chang LS
J Cell Physiol; 2009 Jun; 219(3):642-51. PubMed ID: 19180563
[TBL] [Abstract][Full Text] [Related]
20. Protein-based therapeutic approaches targeting death receptors.
French LE; Tschopp J
Cell Death Differ; 2003 Jan; 10(1):117-23. PubMed ID: 12655300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]